Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

U.S. stock futures were marginally higher on Monday night after the S&P 500 and Nasdaq Composite notched a second winning day ...

And a cute baby hippo bit her zookeeper’s knee in a fit of childish rage, launching a thousand memes. Here’s our ... a Host of Diseases Ozempic, Zepbound, and other GLP-1 drugs seem to boost ...

He explained that while meme stocks might follow similar trends ... The company cited wholesale destocking from Mounjaro and Zepbound for the softer numbers. Many investors took that to mean ...

He explained that while meme stocks might follow similar trends ... The company cited wholesale destocking from Mounjaro and Zepbound for the softer numbers. Many investors took that to mean ...

Elon Musk admits that he uses an infamous weight loss drug akin to Ozempic in a Christmas post while posing in a Santa Claus ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Zepbound is an injectable prescription medication created to help adults with obesity and weight-related problems, including obstructive sleep apnea. OSA causes airway collapses during sleep and ...

Eli Lilly and Company LLY announced that the FDA has approved its popular obesity drug, Zepbound (tirzepatide) for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.